Physician profile
Jay D Patel
NPI 1487008330
$4,494.58
in general payments reported to CMS, 2019-2025
11 companies · $1,491 in 2025
The $1,491 reported for 2025 was more than what 82% of Pediatric Cardiology providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $297 · 2022: $413 · 2023: $2,273 · 2024: $19.40 · 2025: $1,491.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,002 · Food and Beverage: $1,591 · Education: $191.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,001.67 |
| Food and Beverage | $1,590.78 |
| Education | $191.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $2,006.51 | 2021-2025 | Gore Cardioform Septal Occluder, Gore Cardioform Asd Occluder |
| Medtronic, INC. | $1,179.28 | 2025 | Harmony |
| Edwards Lifesciences Corporation | $846.05 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Penumbra, INC. | $172.07 | 2025 | Ruby Coil |
| Abbott Laboratories | $160.55 | 2022 | |
| Kerecis Limited | $36.64 | 2022-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| B. Braun Interventional Systems INC. | $29.03 | 2022 | |
| Azurity Pharmaceuticals, INC. | $25.23 | 2025 | Katerzia |
| Abiomed | $25.00 | 2025 | |
| Bard Peripheral Vascular, INC. | $11.41 | 2021 | |
| Elutia, INC. | $2.81 | 2025 | Ecm Patch,Pouch |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.